New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 8, 2013
10:52 EDTCLDXCelldex stages turnaround, levels to watch
The stock is a mirror image of yesterday's sharp downside action following earnings, that later saw the shares level out to close near the opening gap price near $10.50. Today the stock is up over 13.5%, last at $11.91. Several firms, Cantor, Roth Capital, and Jefferies all raised price targets on the shares this morning, ranging from $15 to $16. At current levels, next resistance is at $12.53, a prior pivot high. Support is at $11.36.
News For CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
16:03 EDTCLDXCelldex completes enrollment in Phase 3 ACT IV study
Subscribe for More Information
December 5, 2014
08:44 EDTCLDXCelldex study should increase visibility, partner potential, says Roth Capital
Subscribe for More Information
December 4, 2014
16:09 EDTCLDXCelldex initiates Phase 2 study of Glembatumumab Vedotin
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use